Strategic partnerships Grow Therapy has actively pursued high-profile partnerships with Stanford Medicine, Amazon and other health providers, signaling strong appetite for enterprise collaborations and EAP enhancements that sales teams can leverage to target large health systems, insurers, and HR programs.

Financial momentum With a Series D led by Goldman Sachs and a broad revenue base in the hundreds of millions, Grow Therapy demonstrates financial firepower and a proven ability to scale, making them a candidate for expanded product integrations, co-marketing, and multi-year enterprise contracts.

Provider-centric model The platform acts as a professional home for independent clinicians, handling payors and tech infra, which reduces friction for sales teams pursuing employer and insurer channels seeking streamlined access to licensed therapists and psychiatrists.

Scale and reach Coverage across 220 million lives and rapid onboarding (start in two days) indicate a broad, scalable network with potential for new payer programs, geographic expansion, and verticals like school systems, corporate benefits, and EAP services.

AI and safety focus A recent research partnership with Stanford to establish clinical safety standards in AI for mental health suggests opportunities to co-sell or co-develop AI-enabled care optimization, risk management products, and compliance-focused offerings for enterprise purchasers.